DSC L15 Pill - orange round, 7mm
Generic Name: edoxaban
Pill with imprint DSC L15 is Orange, Round and has been identified as Savaysa 15 mg. It is supplied by Daiichi Sankyo Co. Ltd.
Savaysa is used in the treatment of Atrial Fibrillation; Prevention of Thromboembolism in Atrial Fibrillation; Pulmonary Embolism; Deep Vein Thrombosis and belongs to the drug class factor Xa inhibitors. Risk cannot be ruled out during pregnancy. Savaysa 15 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for DSC L15
Savaysa
- Generic Name
- edoxaban
- Imprint
- DSC L15
- Strength
- 15 mg
- Color
- Orange
- Size
- 7.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Factor Xa inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Daiichi Sankyo Co. Ltd.
- National Drug Code (NDC)
- 65597-0201
See also:
Xarelto
Xarelto (rivaroxaban) is a factor Xa inhibitor used to reduce the risk of blood clots and stroke in ...
Cardizem
Cardizem is used to treat hypertension (high blood pressure), angina (chest pain), and heart rhythm ...
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
Lanoxin
Lanoxin (digoxin) is used to treat congestive heart failure and atrial fibrillation. Includes ...
Multaq
Multaq (dronedarone) is an antiarrhythmic medication used to treat atrial fibrillation and atrial ...
Propafenone
Propafenone is used for atrial fibrillation, atrial flutter, ventricular tachycardia ...
Sotalol
Sotalol is a beta-blocker with antiarrhythmic properties that affects the heart and circulation ...
Flecainide
Flecainide is used for atrial fibrillation, atrial flutter, paroxysmal supraventricular ...
Rivaroxaban
Rivaroxaban is used for atrial fibrillation, cardiovascular risk reduction, congenital heart ...
More about Savaysa (edoxaban)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: factor Xa inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.